Up-to-date cancer survival: Period analysis and beyond

International Journal of Cancer

Volumn 124, Issue 6, 2009, Pages 1384-1390

  Brenner, Hermann ^a   Hakulinen, Time ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cancer registries; Period analysis; Survival

Indexed keywords

ACCURACY; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; DATA ANALYSIS; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; PATIENT MONITORING; PERIOD ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL MODEL; FEMALE; FEMALE GENITAL TRACT TUMOR; FINLAND; MALE; MALE GENITAL TRACT TUMOR; MORTALITY; NEOPLASM; REGISTER; SURVIVAL; SURVIVOR; TIME;

COHORT STUDIES; FEMALE; FINLAND; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; MALE; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 60549093056     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24021     Document Type: Article

References (27)

1. Brenner H, Gefeller O. An alternative approach to the monitoring of cancer patient survival. Cancer 1996;78:2004-10.
2. Brenner H, Hakulinen T. Up-to-date survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826-32.
3. Brenner H, Söderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31:456-62.
4. Talbäck M, Stenbeck M, Rosén M. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 2004:40:1361-72.
5. Ellison L. An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry. Ann Epidemiol 2006;16:191-6.
6. Steliarova-Foucher E, Arndt V, Parkin DM, Berrino F, Brenner H. Timely disclosure of progress in childhood cancer survival by period analysis in the automated childhood cancer information system. Ami Oncol 2007;18:1554-60.
7. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002;360: 1131-5.
8. Talbäck M, Rosén M, Stenbeck M, Dickman PW. Cancer patient survival in Sweden at the beginning of the third millennium- predictions using period analysis. Cancer Causes Control 2004:15:967-76.
9. Brenner H, Arndt V. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 bv period analysis. J Clin Oncol 2005;23:441-7.
10. Ellison LF, Gibbons L. Survival from cancer-up-to-date predictions using period analysis. Health Rep 2006; 17:19-30.
11. Houterman S, Janssen-Heijnen MLG, van de Poll-Franse LV, Brenner H, Coebergh JWW. Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Ann Oncol 2006;17:709-12.
12. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I, The EUROCARE-4 Working Group. Recent cancer survival In Europe: a 2000-02 period analysis. Lancet Oncol 2007;8:784-96.
13. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model based period analysis. Am J Epidemiol 2006;164:689-96.
14. Brenner H, Hakulinen T. Maximizing the benefits of model based period analysis of cancer patient survival. Cancer Epidemiol Biomarkers Prev 2007;16:1675-81.
15. Brenner H, Hakulinen T. Up-to-date estimates of cancer patient survival even with common latency in cancer registration. Cancer Epidemiol Biomarkers Prev 2006;15:1727-32.
16. Mariotto AB, Wesley MN, Cronin KA, Johnson KA, Feuer EJ. Estimates of long-term survival of newlv diagnosed patients. Cancer 2006;106:2039-50.
17. Brenner H, Hakulinen T. Period versus cohort modeling of up-to-date cancer survival. Int J Cancer 2008; 122:898-904.
18. Berrino F, Capocaccia R, Estéve J, Gatta G, Hakulinen T, Micheli A, Sant M. Verdecchia A, eds. Survival of cancer patients in Europe. The EUROCARE-2 studv. TARC Scientific Publications No. 151. Lyon: IARC, 1999.
19. Berrino F, Capocaccia R, Coleman MP, Estéve J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A, eds. Survival of cancer patients in Europe. The EUROCARE-3 Study. Ann Oncol 2003:14(Suppl 5):v9-vl55.
20. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, Parkin DM. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004; 364:2097-105.
21. Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, Sanquilani M, The EUROCARE Working Group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83.
22. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
23. Teppo L, Pukkaia E, Lehtonen M, Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
24. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
25. Henson DE. Ries LA. The relative survival rate. Cancer 1995;76:1687-8.
26. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10, End Results Section. Bethesda MD: National Cancer Institute, 1959.
27. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data; theory, empirical evaluation, computational realization and applications. Eur J Cancer 2004;40:326-35.